Stephen Schultz | VP, IR |
Justin Gover | CEO & Executive Director |
Darren Cline | U.S. Chief Commercial Officer |
Christopher Tovey | COO |
Volker Knappertz | Chief Medical Officer |
Scott Giacobello | CFO |
Tazeen Ahmad | Bank of America |
Cory Kasimov | JPMorgan |
Salveen Richter | Goldman Sachs. |
Marc Goodman | SVB Leerink |
Paul Matteis | Stifel |
Serge Belanger | Needham |
David Kideckel | ATB Capital Markets |
Neena Bitritto-Garg | CITI |
Yatin Suneja | Guggenheim Partners |
Laura Christianson | Cowen |
Greetings and welcome to the GW Pharmaceuticals Second Quarter 2020 Financial Results Call. [Operator Instructions].As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Stephen Schultz, Vice President, Investor Relations. Thank you, sir.